Self-Improvement and Research Ethics (with Rob Wiblin)
Clearer Thinking with Spencer Greenberg
Navigating FDA Approval and Patient Autonomy
This chapter examines the FDA's role in drug approval and the necessity for clearer labeling standards. It advocates for patient autonomy, proposing that unapproved medications be accessible with adequate warnings to allow informed risk-taking. The conversation also addresses the shortcomings in side effect reporting and the impact of funding on medical research, highlighting the need for systemic improvements in these areas.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
